相关实验视频

Updated: May 17, 2025

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

在临床前研究中用于炎症性肠病的氧马:系统性审查和元分析

Xuan Zhao¹, Xiaolu Ye¹, Yuting Gu¹

¹The First Clinical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.

Frontiers in medicine

|May 15, 2025

概括

在炎症性肠病 (IBD) 的动物模型中,氧化 (OMT) 显著降低了炎症并改善了肠道屏障功能. 这种天然化合物有望通过减轻疾病活动和恢复肠道完整性来治疗IBD.

科学领域:

胃肠病学胃肠病学
药理学药理学是指药理学的学科.
自然产品自然产品

背景情况:

炎症性肠病 (IBD) 是一种慢性肠道炎症状况.
氧氨酸 (OMT),来自Sophora flavescens,表现出抗炎性质.
新兴研究强调了OMT在IBD中的潜在治疗作用.

研究的目的:

在动物模型中系统地审查和元分析氧化 (OMT) 对炎症性肠病 (IBD) 的影响.
评估OMT对关键炎症标志物和肠道屏障功能的影响.
评估OMT作为IBD潜在治疗的整体疗效.

主要方法:

在PubMed,Embase,Web of Science,Cochrane和Medline进行系统的文献搜索.
使用SYRCLE的工具进行偏差风险评估.
通过Web Plot Digitizer 4.2提取数据,并使用STATA 16.0.0进行元分析.

主要成果:

在IBD模型中,OMT干预显著降低了疾病活性指数 (DAI) 和组织病理学得分 (HS).
OMT降低了炎症性细胞因子 (IL-6,IL-1β,TNF-α) 和标志物 (NF-κB,MPO) 的水平.
OMT改善了结肠长度和肠道屏障蛋白的表达 (ZO-1,ocludin),表明屏障保护.

结论:

分析表明,oxymatrine (OMT) 对炎症性肠病 (IBD) 动物模型有积极的影响.
OMT表现出抗炎,抗氧化应激和肠道屏障保护作用.
这些发现为IBD的临床管理提供了新的治疗见解.

关键词:

这是一种炎症炎症炎症炎症.炎症性肠病是一种炎症性肠病.进行元分析.氧化应激是一种氧化应激.氧化氨酸是一种氧化胺.

更多相关视频

Modeling Colitis-Associated Cancer with Azoxymethane AOM and Dextran Sulfate Sodium DSS

Modeling Colitis-Associated Cancer with Azoxymethane AOM and Dextran Sulfate Sodium DSS

Published on: September 11, 2012

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Published on: September 13, 2016

相关概念视频

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Drugs for Treatment of Ulcerative Colitis in IBD

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...